Who We Are:
Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.
The Role: The Associate Director of HCP Promotional Marketing will support the implementation and execution of brand strategy and core messaging for Bezuclastinib’s Non-Advanced & Advanced Systemic Mastocytosis indications, helping to bring a clear, compelling brand narrative to life for HCPs. In this role, you will play a key part in translating strategy into effective field-facing and scientific engagement experiences.
Reporting to the Senior Director of SM Marketing, you will partner closely with cross-functional teams to ensure consistent pull through of messaging across channels and touchpoints. This role offers the opportunity to serve as a strong operational leader, contributing to high quality execution while building influence and expertise within a dynamic, launch focused organization.
Responsibilities:
- Lead execution of the HCP brand strategy, positioning, and core messaging for Non-Advanced & Advanced Systemic Mastocytosis indications, ensuring strong pull-through with the US field sales team and across key promotional touchpoints
- Support the development and update of the Bezuclastinib Brand Plan
- Works cross-functionally including with counterpart leading GIST indication & Patient Marketing, to help team develop and evolve marketing ideas that promote brand goals while ensuring strict compliance with regulations and guidelines
- Serve as the marketing partner for the field, translating brand strategy and complex scientific concepts into clear, actionable execution guidance to drive effective HCP engagement
- Support the development, review, and approval of compliant derivative promotional materials that extend core brand messaging across channels
- Support planning and execution of promotional congress and major meeting activities
- Partner closely with Sales Leadership and Field Learning & Development to support field meetings, training material, and ongoing field enablement initiatives
- Monitor field feedback, marketplace insights, and competitive dynamics to inform ongoing optimization of messaging and execution
- Translate clinical data and strategic direction into compelling, compliant derivative promotional materials
- Support refinement of messaging based on evolving data, competitive landscape, and field insights
- Collaborate cross-functionally with Medical, Legal, Regulatory, Market Access, and Insights and Operations to ensure high-quality, compliant execution
- Performs effective Agency of Record and vendor management; ensures appropriate balance of internal and external resources to drive campaign execution in a manner that achieves best ROI
- Manage a budget/resourcing plan for the HCP marketing function and tracks financial spending and adjustments with high acumen
- Demonstrates agility and flexibility, as part of a nimble, entrepreneurial organization
- Travel as needed to support congresses, field visits, and key business priorities
Qualifications:
- Bachelor's degree in Business, Marketing, or a related field; MBA or advanced degree a plus
- Minimum of 7+ years of pharmaceutical or biotech commercial experience, including HCP marketing experience in rare disease and/or oncology a plus
- Demonstrated experience supporting commercial launch activities and/or pre-launch activities
- Strong scientific acumen with demonstrated ability to interpret and translate complex clinical data into impactful, compliant HCP materials and field communications
- Proven project management skills with ability to manage multiple workstreams in a fast-paced, launch-focused environment
- Excellent communication skills with the ability to influence and lead through collaboration without direct authority
- Strong cross-functional experience with Marketing, Insights, Market Access, Medical, Legal, and Compliance
- Track record of operating with high integrity and maintaining compliance with regulatory, legal, and operational standards
- Ability to thrive in evolving, dynamic, and fast-paced pre-launch or launch-phase environments with shifting data and priorities
- Willingness to travel as business needs require
Salary Range:
$190,000 - 225,000 USD
Waltham, MA: Our headquarters is located in the Greater Boston life sciences community, with an open, collaborative office environment designed to support teamwork and connection. Employees benefit from convenient on-site amenities, including free on-site parking and gym facilities in the building.
Boulder, CO: Our Boulder location is home to Cogent’s discovery research organization and a key scientific hub with strong leadership based on site. Situated in the greater Denver-Boulder biopharmaceutical corridor, this office plays a central role in advancing our discovery efforts and pipeline.
Our Offer To You
At Cogent Biosciences, we offer a competitive salary, bonus, and ongoing stock awards, alongside a benefits package that sets us apart. We cover 100% of medical, dental, and vision premiums for you and your family, and help reduce out-of-pocket costs by funding up to 75% of in-network deductibles. Our benefits also include a 401(k) match with immediate vesting, generous paid time off, 12 weeks of fully paid parental leave, paid family and medical leave for all employees regardless of location, and company-paid short-term disability coverage for up to 20 weeks. Additional perks like wellness programs, tuition reimbursement, and inclusive family-forming support help you thrive at work and beyond.
We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.
Skills Required
- Bachelor's degree in Business, Marketing, or a related field; MBA or advanced degree a plus
- Minimum of 7+ years of pharmaceutical or biotech commercial experience, including HCP marketing experience in rare disease and/or oncology
- Demonstrated experience supporting commercial launch activities and/or pre-launch activities
- Strong scientific acumen with demonstrated ability to interpret and translate complex clinical data into impactful, compliant HCP materials
- Proven project management skills with ability to manage multiple workstreams in a fast-paced, launch-focused environment
- Excellent communication skills with the ability to influence and lead through collaboration without direct authority
- Strong cross-functional experience with Marketing, Insights, Market Access, Medical, Legal, and Compliance
- Track record of operating with high integrity and maintaining compliance with regulatory, legal, and operational standards
- Ability to thrive in evolving, dynamic, and fast-paced pre-launch or launch-phase environments with shifting data and priorities
- Willingness to travel as business needs require
What We Do
Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on rational drug discovery and development, we are leveraging validated biology to advance precision therapies designed to address the true underlying drivers of disease and provide real hope for patients. Cogent’s lead therapeutic candidate, bezuclastinib (CGT9486), is a precision kinase inhibitor designed to selectively and potently inhibit the KIT D816V mutation. This mutation is responsible for driving a rare and serious condition called Systemic Mastocytosis which can severely impact many different tissues and organs in the body. We are also studying CGT9486 to treat advanced gastrointestinal stromal tumors (GIST), which have a strong dependence on oncogenic KIT signaling.
